Home > Browse Reports > Medical Devices > Disposable Medical Supplies Markets

Report Description

Disposable Medical Supplies Markets
Publication Date: 01-AUG-09
Pages: 247
Study: TMRDMS
Format/Price: PDF document / $3,400.00
   


Description:



View Sample PDF

This report is intended to provide basic marketing data pertaining to the U.S. and worldwide market segments of the disposable medical supplies market, including: surgical gowns, surgical drapes, isolation gowns, surgical and examination gloves, institutional incontinence disposables, operating room (OR) custom kits and trays, non-OR custom packs, shoe covers, masks, disposable coveralls and lab coats, headwear, protective eyewear, sterile wipes, swabs and mops. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally.





Table of Contents:

  1. 1. Introduction 12
  2. 1.1 Objectives 13
  3. 1.2 Scope 13
  4. 1.3 Methodology 13
  5. 1.4 Executive Summary 14
  6. 2. Disposable Medical Supplies Market 16
  7. 2.1 Overview 16
  8. 2.2 Outlook for Disposable Medical Supplies in the U.S. 17
  9. 2.3 Medical Device and Supplies Market in Russia 18
  10. 2.4 Medical Devices and Supplies Market in Europe 18
  11. 2.4.1 Germany 18
  12. 2.4.2 France 19
  13. 2.4.3 Italy 19
  14. 2.4.4 U.K. 19
  15. 2.4.5 Denmark 20
  16. 2.5 The Outlook for Medical Devices and Supplies in South East Asia in 2013 21
  17. 2.5.1 Indonesia 21
  18. 2.5.2 Malaysia 21
  19. 2.5.3 Philippines 21
  20. 2.5.4 Singapore 21
  21. 2.5.5 South Korea 22
  22. 2.5.6 Taiwan 23
  23. 2.5.7 Thailand 23
  24. 2.5.8 Vietnam 23
  25. 3. Market for U.S. Nanotechnology Healthcare Products 24
  26. 3.1 Nanotechnology for Therapeutics 25
  27. 3.2 Nanotechnology for Cancer Treatment 25
  28. 3.3 Nanotechnology for the Treatment of Anemia 26
  29. 3.4 Nanotechnology for Vaccines 26
  30. 3.5 Implants 26
  31. 3.6 Tissue Engineering 27
  32. 3.7 Sensors 27
  33. 3.8 Stents 27
  34. 3.9 Nanostructured TiOx Ultra Thin Films 28
  35. 3.10 Drug Delivery 28
  36. 3.11 Heat Therapy 28
  37. 3.12 MRI/X-Ray 28
  38. 3.13 Bone Cement 28
  39. 3.14 Nanofiber 28
  40. 4. Medical Design Excellence Awards for Medical Disposables 29
  41. 4.1 Winning Disposable Medical Products and Supplies 29
  42. 4.1.1 LiquiBand Optima Wound-Closure Adhesive 29
  43. 4.1.2 Styla MicroLaser Advanced Dental Laser System 30
  44. 4.1.3 UniDose Glucose Meter Check Control 30
  45. 4.1.4 Interfuse Interbody Fusion Device 30
  46. 4.1.5 iUni and iDuo (Unicompartmental and Bicompartmental) Knee Resurfacing Devices 31
  47. 4.1.6 INRatio2 Blood Coagulation Monitor 31
  48. 4.1.7 Spectra MRSA Chromogenic-Plated Medium 32
  49. 4.1.8 TRUE2go Portable Glucose Monitor 32
  50. 4.1.9 Bunion Aid Splint 33
  51. 4.1.10 Accu-Right CT Marker Device 33
  52. 4.1.11 Provent Professional Sleep Apnea Therapy 34
  53. 4.1.12 Whiz Freedom Hygienic Urine Director 34
  54. 4.1.13 HemCon® Bandage 35
  55. 4.1.14 Veramyst™ (Fluticasone Furoate) and Avamys Nasal Spray Delivery Device 35
  56. 4.1.15 Akreos® AO Microincision Lens, Model MI60 36
  57. 4.1.16 GeeWhiz Male External Condom Catheter 36
  58. 4.1.17 Natural Nurser™ Baby Bottle 36
  59. 4.1.18 NovoFine® Autocover™ Automatic Safety Pen Needle 37
  60. 4.1.19 Uresta™ Continence Care Kit 37
  61. 4.1.20 InteguSeal™ Microbial Sealant 37
  62. 4.1.21 Patient Registration Mask 38
  63. 4.1.22 Thermoplastic Drill Template Set 38
  64. 4.1.23 Ospol Dental Implant System Packaging 39
  65. 4.1.24 Episure™ AutoDetect Epidural Syringe 39
  66. 4.1.25 Odor Absorbing Hydrocolloid Wound Dressing 40
  67. 4.1.26 SureSkin® Central Catheter and I.V. Dressing 40
  68. 4.1.27 Gynecare TVT Secur™ System for Treating Stress Urinary Incontinence 40
  69. 4.1.28 Conveen® Optima Silicone Urisheath 41
  70. 4.1.29 eFlow® Electronic Nebulizer 41
  71. 4.1.30 OptraGate® 41
  72. 4.1.31 RelyX™ Luting Plus Cement 42
  73. 4.1.32 3M™ Foam Adhesive Dressing 42
  74. 4.1.33 ClozeX Wound Closure Device 42
  75. 5. Global Market for Non-Wovens 43
  76. 5.1 Non-Wovens in China 44
  77. 5.2 Medical Non-Wovens 45
  78. 5.3 Materials Used in Medical Non-Wovens 46
  79. 5.4 Global Medical Non-Woven Disposables Market 48
  80. 6. Contact Lens 50
  81. 6.1 The History of Contact Lenses 50
  82. 6.1.1 The Early Years-Glass Contact Lenses 50
  83. 6.1.2 The Introduction of Hard Plastic Lenses 50
  84. 6.1.3 The Soft Contact Lens Revolution 50
  85. 6.2 Highlights in Contact Lens History 51
  86. 6.3 Contact Lenses and Children 52
  87. 6.4 Extended Wear Contact Lenses 52
  88. 6.5 30-Day Extended Wear Lenses 53
  89. 6.6 Flexible Wear 53
  90. 6.7 Replacing Contact Lenses 53
  91. 6.8 The Most Popular Contact Lenses Currently on the Market 54
  92. 6.9 Contact Lenses in the U.S. 54
  93. 6.10 Facts about Contact Lenses Everyone Ought to Know 57
  94. 6.11 Contact Lens Spectrum's Survey in 2008 58
  95. 6.12 Contact Lens Comfort 62
  96. 6.13 Contact Lens Safety 62
  97. 6.14 International Contact Lens Prescribing in 2008 63
  98. 6.15 Contact Lens Wearer Demographics 64
  99. 6.16 Rigid Lenses 65
  100. 6.17 Soft Lenses 68
  101. 6.18 Soft Contact Lens Market in Selected Western Markets 68
  102. 6.19 Contact Lenses in the U.K. 70
  103. 7. Medical Sealants 73
  104. 7.1 European Tissue Sealants Market 73
  105. 7.2 U.S. Market for Medical Adhesives and Sealants 74
  106. 8. Blood Glucose Strips 76
  107. 8.1 Self-Monitoring Glucose Device Markets in Asia Pacific 76
  108. 8.2 Competition among the Leading Players 77
  109. 8.3 Glucometer Market in India 78
  110. 9. Pre-filled Syringes 79
  111. 9.1 Need for Pre-filled Syringes 79
  112. 9.2 Glass vs. Plastic 79
  113. 9.3 Interaction of Drugs and Packaging 80
  114. 9.4 Cycloolefin-Copolymers 80
  115. 9.5 Increasing Popularity of Pre-filled Syringes 80
  116. 9.6 Advantages and Driving Factors of Pre-filled Syringes 81
  117. 9.7 Current Market and Requirements 81
  118. 9.8 Continuous Innovation for Safer Injections 82
  119. 10. Gloves 83
  120. 10.1 Market Overview 83
  121. 10.2 Market Share of Nitrile Gloves 84
  122. 10.3 The Surgical Glove Market in Europe: Key Players 85
  123. 10.3.1 Surgical Gloves Market in Portugal 86
  124. 10.3.2 Production of Gloves 86
  125. 10.4 Malaysia's Rubber Gloves 87
  126. 10.4.1 Trends in Glove Production in Malaysia 89
  127. 10.5 FDA Authority over Medical Gloves 91
  128. 10.6 Medical Gloves and the ASTM 91
  129. 10.6.1 ASTM Testing of Medical Gloves 92
  130. 10.7 Advances in Surgical Gloves 94
  131. 10.7.1 Dermal Coatings 94
  132. 10.7.2 Latex-free with Improved Fit and Feel 94
  133. 10.7.3 Powder-free Latex Gloves 94
  134. 10.7.4 Preventing Slip-down 94
  135. 10.7.5 Smooth or "Grippy" 94
  136. 10.7.6 Easier Donning 95
  137. 10.7.7 Reduced Irritants 95
  138. 10.8 Competitive Overview 95
  139. 10.9 Choosing the Best Medical Glove 96
  140. 10.9.1 Natural Rubber Latex Gloves (NRL) 96
  141. 10.9.2 Polyvinyl Chloride 97
  142. 10.9.3 Butadiene-Acrylonitrile 97
  143. 10.9.4 Polychloroprene 97
  144. 10.9.5 Styrene-Butadiene Rubber, Styrene-Ethylene-Butadiene-Styrene and Polyurethane 97
  145. 10.10 Problems Associated with Gloves 98
  146. 10.10.1 Latex Allergy 98
  147. 10.10.2 Glove Powder 98
  148. 10.10.3 Pyrogens and Endotoxins 98
  149. 10.11 Product Overview 98
  150. 10.11.1 Esteem® Glove from Cardinal Health 98
  151. 10.11.2 DermaPrene Ultra from Ansell Healthcare 100
  152. 10.11.3 Biogel® Super-Sensitive™ Glove from Mölnlycke HealthCare 100
  153. 10.11.4 Aloetouch® Gloves from Medline 101
  154. 10.11.5 Sempermed® Examination Gloves 102
  155. 10.11.6 Kimberly-Clark Safeskin® 102
  156. 11. Catheters 104
  157. 12. Wound Care Market 107
  158. 12.1 Advanced Wound Care 107
  159. 12.2 Moist Wound Dressings 108
  160. 12.2.1 Moist Wound Care: The Benefits 108
  161. 12.2.2 Hydrogels 108
  162. 12.2.3 Hydrocolloids 108
  163. 12.2.4 Alginates 109
  164. 12.2.5 Antimicrobials 109
  165. 12.3 Active Wound Products 109
  166. 12.4 Market Leaders 109
  167. 12.5 Chronic Wounds 109
  168. 12.6 Silver Dressings 109
  169. 12.7 Commercially Available Silver-containing Dressings 110
  170. 12.7.1 Acticoat-Smith and Nephew 110
  171. 12.7.2 Actisorb Silver 220-Johnson & Johnson 110
  172. 12.7.3 Arglaes-Unomedical/Medline 110
  173. 12.7.4 Aquacel Ag-ConvaTec 110
  174. 12.7.5 Calgitrol-Biomedical Technologies, Inc. 110
  175. 12.7.6 Contreet Foam-Coloplast 111
  176. 12.7.7 Contreet Hydrocolloid-Coloplast 111
  177. 12.7.8 Silverlon-Argentum Medical 111
  178. 12.7.9 SilvaSorb-Medline 111
  179. 12.7.10 Urgotul SSD-Laboratoires Urgo (Parema) 111
  180. 13. Market for Other Infection Prevention Products 112
  181. 13.1 Surgical Gowns 112
  182. 13.1.1 Size and Growth Rate of the Market 112
  183. 13.1.2 Surgical Gowns from Kimberly-Clark 114
  184. 13.1.3 Cardinal Health Corp. 114
  185. 13.1.4 Medical Gowns from Medline Industries 115
  186. 13.1.5 Medical Gowns from Mölnlycke HealthCare 116
  187. 13.1.6 3M 117
  188. 13.2 Surgical Drapes 118
  189. 13.3 Isolation Gowns 118
  190. 13.3.1 Growth Rate of the Market 119
  191. 13.4 Custom Kits and Trays 120
  192. 13.4.1 Market Growth 122
  193. 13.4.2 Custom Kits and Trays from DeRoyal 123
  194. 13.4.2.1 Ophthalmic Custom Procedure Trays 123
  195. 13.4.3 Custom Kits and Trays from Medline 124
  196. 13.4.3.1 Laceration Tray 124
  197. 13.5 Shoe Covers 125
  198. 13.5.1 Market Size 125
  199. 13.6 Masks 126
  200. 13.6.1 Market Size 126
  201. 13.6.2 Product Overview 128
  202. 13.6.3 Filtron™ Mask from 3M HealthCare 128
  203. 13.6.4 Fluidshield® Mask from Kimberly-Clark 128
  204. 13.6.5 Secure-Gard® Mask from Cardinal Health 129
  205. 13.7 Disposable Coveralls 131
  206. 13.7.1 Market Size 131
  207. 13.7.2 Market Growth 131
  208. 13.8 Disposable Lab Coats 132
  209. 13.8.1 Market Size 132
  210. 13.8.2 Market Growth 133
  211. 13.9 Headwear 134
  212. 13.9.1 Market Size 134
  213. 13.9.2 Market Growth 134
  214. 13.10 Protective Eyewear-Market Size 135
  215. 13.11 Disposable Sterile Wipes (Pre-Saturated and Dry) 136
  216. 14. Company Profiles 138
  217. 14.1 Terumo Medical 138
  218. 14.1.1 Hospital Equipments 140
  219. 14.1.2 Pharmaceuticals 141
  220. 14.1.3 Blood Transfusion Systems 141
  221. 14.1.4 Interventional Systems 141
  222. 14.1.5 Cardiovascular Systems 142
  223. 14.1.6 Peritoneal Dialysis Systems 142
  224. 14.1.7 Diabetes Care Systems 142
  225. 14.1.8 Other Home Healthcare Products 142
  226. 14.1.9 Terumo's Market in Japan 143
  227. 14.1.10 Terumo's Market in Europe 143
  228. 14.1.11 Terumo's Market in North and South America 144
  229. 14.1.12 Terumo's Market in Asia and Others 145
  230. 14.1.13 Terumo's R&D 145
  231. 14.1.14 Terumo's Entry into U.S., Europe and Vietnam 146
  232. 14.1.15 Terumo's I.V. Catheters and Accessories 147
  233. 14.1.16 Sunshield Safety I.V. Catheter 147
  234. 14.1.17 Surflo Teflon I.V. Catheter 147
  235. 14.1.18 SurFlash Polyurethane I.V. Catheter 147
  236. 14.1.19 Insulin Syringes 147
  237. 14.1.20 Winged Needle Sets and Accessories 148
  238. 14.2 Abbott 148
  239. 14.2.1 Abbott's Immunology Products 148
  240. 14.2.2 Abbott's Vascular Products 149
  241. 14.2.3 Abbott's Neuroscience Products 149
  242. 14.2.4 Abbott's Oncology Products 149
  243. 14.2.5 Abbott's Medical Products 150
  244. 14.3 Rochester Medical Corporation 151
  245. 14.3.1 Male External Catheters 151
  246. 14.3.2 Intermittent Catheters 151
  247. 14.3.3 Foley Catheters 152
  248. 14.3.4 Global Sales 152
  249. 14.4 Medtronic 153
  250. 14.5 Merit Medical Systems, Inc. 155
  251. 14.5.1 Merit's Products 156
  252. 14.5.2 Inflation Devices 156
  253. 14.5.3 Hemostasis Valves 156
  254. 14.5.4 Vascular Access Products 156
  255. 14.5.5 Diagnostic Catheters, Guide Wires and Torque Devices 156
  256. 14.5.6 Angiography and Angioplasty Accessories 157
  257. 14.5.7 Safety and Waste Management Systems 157
  258. 14.5.8 Obesity-related Products 157
  259. 14.5.9 Drainage Catheters and Accessories 157
  260. 14.5.10 Paracentesis and Pericardiocentesis Catheters 157
  261. 14.5.11 Therapeutic Infusion Catheters 158
  262. 14.5.12 Products for Dialysis and Interventional Nephrology 158
  263. 14.5.13 Research and Development 158
  264. 14.5.14 Net Sales 159
  265. 14.6 St. Jude Medical, Inc. 159
  266. 14.6.1 Cardiac Rhythm Management 161
  267. 14.6.2 Cardiovascular 161
  268. 14.6.3 Atrial Fibrillation 161
  269. 14.6.4 Neuromodulation 162
  270. 14.6.5 Research and Development 163
  271. 14.7 Teleflex Medical 163
  272. 14.7.1 Venous Access 163
  273. 14.7.2 Urology Products 163
  274. 14.7.3 Anesthesia and Airway Management 163
  275. 14.7.4 Respiratory 164
  276. 14.7.5 Surgical Devices and Instruments 164
  277. 14.7.6 Teleflex Medical OEM 164
  278. 14.7.7 Cardiac Care 164
  279. 14.8 Smith & Nephew 165
  280. 14.8.1 Orthopedics 165
  281. 14.8.2 Endoscopy 166
  282. 14.8.3 Advanced Wound Management 166
  283. 14.8.4 Research and Development 166
  284. 14.9 Johnson & Johnson Medical and Product Offering 168
  285. 14.10 Semperit Aktiengesellschaft Holding (SAG) and Product Offering 172
  286. 14.11 Alcon Laboratories, Inc. and Product Offering 177
  287. 14.11.1 Alcon's Highlights in 2008 178
  288. 14.12 B. Braun and Product Offering 184
  289. 14.12.1 Performance of B. Braun's Division 190
  290. 14.12.2 Selected Medical Supplies from B. Braun 192
  291. 14.13 C. R. Bard, Inc. and Product Offering 194
  292. 14.13.1 Bard's Vascular Business 194
  293. 14.13.2 Bard's Key Products in Vascular Business 195
  294. 14.13.3 Bard's Urology Business 196
  295. 14.13.4 Bard's Key Products in Urology Business 197
  296. 14.13.5 Bard's Oncology Business 198
  297. 14.13.6 Bard's Key Oncology Products 199
  298. 14.13.7 Bard's Surgical Specialties 199
  299. 14.13.8 Bard's Key Products in Surgical Specialties 200
  300. 14.13.9 Bard's Overseas Business 200
  301. 14.14 Cardinal Health, Inc. and Product Offering 201
  302. 14.14.1 Healthcare Supply Chain Services 201
  303. 14.14.2 Clinical and Medical Products 201
  304. 14.15 Contec, Inc. and Product Offering 203
  305. 14.16 Ansell Occupational Healthcare and Product Offering 204
  306. 14.17 DeRoyal Industries, Inc. and Product Offering 206
  307. 14.18 Ecolab 209
  308. 14.19 Covidien Ltd. 214
  309. 14.19.1 Covidien's Medical Devices 215
  310. 14.19.2 Covidien's Imaging Solutions 216
  311. 14.19.3 Covidien's Pharmaceutical Products 217
  312. 14.19.4 Covidien's Medical Supplies 217
  313. 14.19.5 Covidien's Manufacturing Locations 219
  314. 14.19.6 Healthcare Products from Covidien 219
  315. 14.19.7 Selected Products from Covidien's Brands 220
  316. 14.20 Kimberly-Clark and Product Offering 222
  317. 14.21 Medline Industries, Inc. and Product Offerings 226
  318. 14.22 3M HealthCare and Product Offering 227
  319. 14.23 Alpha Pro Tech Ltd. and Product Offering 231
  320. 14.23.1 Alpha Pro Tech's Business Segments 232
  321. 14.24 Graham Medical and Product Offering 233
  322. 14.25 BBA Fiberweb and Product Offering 235
  323. 14.26 Dynarex Corp. and Product Offering 237
  324. 14.27 Paul Hartmann AG and Product Offering 238
  325. 14.28 Ahlstrom Corp. and Product Offering 247
  326. 14.29 Ansell Ltd. and Product Offering 253
  327. 14.30 Baxter International, Inc. and Product Offering 255
  328. 14.31 BD Medical (Becton, Dickinson and Company) and Product Offering 258
  329. 14.31.1 BD Medical Segment 259
  330. 14.31.2 BD Diagnostics Segment 259
  331. 14.31.3 BD Biosciences Segment 260
  332. 14.32 Boston Scientific Corporation and Product Offering 262
  333. 14.32.1 Boston's Products 263
  334. 14.32.2 Cardiac Rhythm Management (CRM) 263
  335. 14.32.3 Electrophysiology 265
  336. 14.32.4 Interventional Cardiology 265
  337. 14.32.5 Peripheral Interventions 266
  338. 14.32.6 Non-Vascular Intervention 266
  339. 14.32.7 Endosurgery 266
  340. 14.32.8 Neuromodulation 267
  341. 14.33 Coloplast Ltd. and Product Offering 268
  342. 14.33.1 Coloplast's Ostomy Care 268
  343. 14.33.2 Urology and Continence Care 269
  344. 14.33.3 Wound and Skincare 269
  345. 14.33.4 Coloplast's Geographical Markets 269
  346. 14.34 Top Glove Corporation Bhd 272
  347. INDEX OF FIGURES
  348. Figure 2.1: Global Disposable Medical Supplies Market by Geographical Segment, 2008 16
  349. Figure 2.2: Estimated Growth of Disposable Medical Supplies Market in the U.S., 2007-2009 17
  350. Figure 2.3: Estimated Growth of Disposable Medical Supplies in Russia, 2008-2012 18
  351. Figure 2.4: Estimated Growth of German Medical Device and Supplies Market, 2007-2012 19
  352. Figure 2.5: E.U. Medical Devices and Supplies Market, 2005-2008 20
  353. Figure 5.1: Worldwide Non-Woven Production, 1994-2009 43
  354. Figure 5.2: Non-Woven Production in Asia Pacific Region, 2004 and 2009 44
  355. Figure 5.3: Share of Medical Textiles in Non-Wovens by Volume 48
  356. Figure 6.1: Soft Contact Lens Wear in the U.S. by Lens Design 55
  357. Figure 6.2: Soft Contact Lens Wear in the U.S. by Wearing Schedule, 2006 56
  358. Figure 6.3: Soft Contact Lens Wear in the U.S. by Replacement Schedule, 2006 56
  359. Figure 6.4: Percentage of Contact Lens Wearers in the U.S. by Sex, 2006 57
  360. Figure 6.5: Lens Dispensing Trends, 2008 58
  361. Figure 6.6: Distribution of Materials Used in Fitting and Refitting, 2008 59
  362. Figure 6.7: Distribution of Replacement Schedules Used with Soft Lens Patients, 2008 59
  363. Figure 6.8: Global Soft Contact Lens Sales, 2008 and 2013 60
  364. Figure 6.9: Market Share of all Soft Lens Disinfectants, 2008 61
  365. Figure 6.10: Global Soft Contact Lens Market Share by Competitor, 2008 61
  366. Figure 6.11: Rigid Lens Designs, 2006-2008 65
  367. Figure 6.12: World Average Lens Market, 2008 68
  368. Figure 6.13: Split of Soft Contact Lens Market Segments, 2008 69
  369. Figure 6.14: Sight Tests in the U.K., 2006-2008 71
  370. Figure 6.15: Contact Lens Market in the U.K. by Product Type, 2007 71
  371. Figure 7.1: Global Market for Medical Adhesives and Sealants, 2006-2012 74
  372. Figure 8.1: Asia Pacific SMBG Competitive Market Share, 2008 78
  373. Figure 9.1: Market Growth for Pre-filled Syringes, 2006-2010 81
  374. Figure 9.2: Market Growth for Self-Injection Devices, 2006-2010 82
  375. Figure 10.1: Major Exporters of Medical Rubber Gloves, 2008 83
  376. Figure 10.2: Global Annual Demand of Gloves, 2004-2008 84
  377. Figure 10.3: Breakdown of Malaysian Rubber Gloves Export, 2008 88
  378. Figure 10.4: Malaysian Medical Gloves Export, 2002-2007 88
  379. Figure 10.5: Malaysia's Natural Rubber Consumption by Sector, 2008 89
  380. Figure 10.6: The Resilient Glove Makers in Malaysia and their Market Share, 2008-2010 90
  381. Figure 14.1: Terumo's Net Sales, 2003-2007 138
  382. Figure 14.2: Terumo's Net Sales Breakdown by Business Segment, 2007 139
  383. Figure 14.3: Terumo's Net Sales Breakdown by Geographic Segment, 2007 139
  384. Figure 14.4: Terumo's Sales of Pre-filled Syringes, 2005-2007 140
  385. Figure 14.5: Terumo's Sales of General Hospital Products, 2006 and 2007 140
  386. Figure 14.6: Terumo's Sales of Cardiac and Vascular Products, 2006 and 2007 141
  387. Figure 14.7: Terumo's Sales of Home Healthcare Products, 2006 and 2007 142
  388. Figure 14.8: Terumo's Net Sales in Japan, 2003-2007 143
  389. Figure 14.9: Terumo's Net Sales in Europe, 2003-2007 144
  390. Figure 14.10: Terumo's Net Sales in North and South America, 2003-2007 144
  391. Figure 14.11: Terumo's Sales in Asia and other Countries, 2003-2007 145
  392. Figure 14.12: Terumo's R&D Expenditure, 2003-2007 146
  393. Figure 14.13: Abbott's Worldwide Net Sales, 2006-2008 150
  394. Figure 14.14: Rochester's Net Sales, 2004-2008 152
  395. Figure 14.15: Medtronic's Net Sales, 2004-2008 153
  396. Figure 14.16: Medtronic's U.S. Net Sales vs. Non-U.S. Net Sales, 2006-2008 155
  397. Figure 14.17: Merit's R&D Expenditure, 2006-2008 158
  398. Figure 14.18: Merit's Net Sales, 2004-2008 159
  399. Figure 14.19: St. Jude's Net Sales by Geographical Region, 2008 160
  400. Figure 14.20: St. Jude's Net Sales, 2004-2008 160
  401. Figure 14.21: St. Jude's Revenue from Atrial Fibrillation Segment, 2006-2008 162
  402. Figure 14.22: St. Jude's Revenue from Neuromodulation Devices, 2006-2008 162
  403. Figure 14.23: St. Jude's R&D Expenditure, 2006-2008 163
  404. Figure 14.24: Teleflex's Percent Revenue by Product Category, 2008 164
  405. Figure 14.25: Smith & Nephew's R&D Expenditure, 2006-2008 167
  406. Figure 14.26: Smith & Nephew's Revenue by Business Segment, 2008 167
  407. Figure 14.27: Smith & Nephew's Revenue by Geographic Market, 2008 168
  408. Figure 14.28: Johnson & Johnson's Net Sales, 2004-2008 168
  409. Figure 14.29: Johnson & Johnson's Consumer Segment Sales, 2008 169
  410. Figure 14.30: Johnson & Johnson's Medical Devices and Diagnostic Segment Sales, 2008 170
  411. Figure 14.31: Johnson and Johnson's Pharmaceutical Segment Sales, 2008 171
  412. Figure 14.32: Semperit's Revenue by Division, 2008 173
  413. Figure 14.33: Semperit's Revenue by Region, 2008 173
  414. Figure 14.34: Sempermed's Revenue, 2004-2008 174
  415. Figure 14.35: Sempermed's Revenue, 1997-2008 175
  416. Figure 14.36: Alcon's Global Sales, 2004-2008 177
  417. Figure 14.37: Alcon's Geographic Revenue Split, 2008 179
  418. Figure 14.38: Alcon's Annual Percentage of Cataract Procedures over 65 Years, 2008 179
  419. Figure 14.39: Alcon's R&D Expenditure, 2004-2008 180
  420. Figure 14.40: Alcon's R&D Expenditures by Therapeutic Category, 2008 180
  421. Figure 14.41: Alcon's Global Surgical Percentage Market Share, 2004-2008 181
  422. Figure 14.42: Alcon's U.S. Contact Lens Care Solutions Equivalent Market Share, 2008 181
  423. Figure 14.43: Alcon's Leadership in Global Market Share in Intraocular Lenses, 2004-2008 182
  424. Figure 14.44: U.S. Market Share of Alcon's Patanol/Pataday, 2008 182
  425. Figure 14.45: Alcon's Global Surgical Revenues, 2004-2008 183
  426. Figure 14.46: Alcon's Global Pharmaceutical Revenues, 2004-2008 183
  427. Figure 14.47: Alcon's Global Consumer Revenues, 2004-2008 184
  428. Figure 14.48: B. Braun's Sales by Region, 2008 188
  429. Figure 14.49: B. Braun's Sales, 2006-2008 189
  430. Figure 14.50: B. Braun's Sales by Division, 2008 190
  431. Figure 14.51: B. Braun's Sales by Division, 2007 and 2008 191
  432. Figure 14.52: B. Braun's Employees by Region, 2008 191
  433. Figure 14.53: C.R. Bard's Net Sales, 2006-2008 194
  434. Figure 14.54: Bard's Vascular Business: Net Sales, 2004-2008 195
  435. Figure 14.55: Bard's Vascular Segment Sales, 2008 195
  436. Figure 14.56: Bard's Urology Business: Net Sales, 2004-2008 196
  437. Figure 14.57: Bard's Urology Products Percent Sales, 2008 197
  438. Figure 14.58: Bard's Oncology Business: Net Sales, 2004-2008 198
  439. Figure 14.59: Bard's Oncology Products Sales, 2008 198
  440. Figure 14.60: Bard's Surgical Specialties Business: Net Sales, 2004-2008 199
  441. Figure 14.61: Bard's Surgical Specialty Products Sales, 2008 200
  442. Figure 14.62: Cardinal's Revenue from Healthcare Supply Chain Services, 2006-2008 201
  443. Figure 14.63: Cardinal's Revenue from Clinical and Medical Products Segment, 2006-2008 202
  444. Figure 14.64: Cardinal's Consolidated Revenue, 2006-2008 202
  445. Figure 14.65: Ansell's Sales by Geography, 2008 205
  446. Figure 14.66: Ecolab's Net Sales, 2004-2008 211
  447. Figure 14.67: Covidien's R&D, 2006-2008 218
  448. Figure 14.68: Covidien's Manufacturing Production by Region, 2008 219
  449. Figure 14.69: Kimberly-Clark's Profile by Segment, 2008 223
  450. Figure 14.70: Kimberly-Clark's Profile by Geography, 2008 223
  451. Figure 14.71: Kimberly-Cark's R&D Expenditure, 2006-2008 224
  452. Figure 14.72: Alpha Pro Tech's Sales Revenue, 2004-2008 232
  453. Figure 14.73: Fiberweb's Hygiene Revenue by Division, 2007 and 2008 236
  454. Figure 14.74: Revenue from Fiberweb's Hygiene Division, 2007 and 2008 236
  455. Figure 14.75: Hartmann's Share of Total Sales by Business Segment, 2008 238
  456. Figure 14.76: Hartmann's Share of Total Sales by Region, 2008 239
  457. Figure 14.77: Ahlstrom's Net Sales by Business Area, 2008 248
  458. Figure 14.78: Ahlstrom's Market by Geography, 2007 249
  459. Figure 14.79: Ahlstrom's Net Sales by Segment, 2007 250
  460. Figure 14.80: Baxter's Revenue, 2006-2008 255
  461. Figure 14.81: BD's Revenues, 2005-2008 258
  462. Figure 14.82: BD's Segmental Revenue, 2008 261
  463. Figure 14.83: Boston's Net Sales, 2004-2008 263
  464. Figure 14.84: Top Glove Corporation's Revenue, 2004-2008 272
  465. Figure 14.85: Top Glove Corporation's Business by Region, 2008 273
  466. INDEX OF TABLES
  467. Table 2.1: E.U. Medical Supplies and Equipment Market by Category, 2007 and 2008 20
  468. Table 3.1: U.S. Nanotechnology Healthcare Products Demand, 2004-2014 25
  469. Table 5.1: Application of Non-Wovens in the Medical Arena 47
  470. Table 5.2: Major Players in the Medical Non-Woven Market 49
  471. Table 6.1: Popular Extended Wear Contact Lenses, 2008 53
  472. Table 6.2: Contact Lens Innovations, 2008 63
  473. Table 6.3: Demographic Information for the 27 Countries Surveyed, 2008 64
  474. Table 6.4: Breakdown of Lens Fits into Six Key Categories of Lenses 66
  475. Table 6.5: Detailed Information for Prescribed Rigid Lenses Only 67
  476. Table 6.6: Lens Care Products: Size of Multipurpose Solutions (MPS) Segment vs. Hydrogen Peroxide- (HP) Based Solutions by Country, 2008 69
  477. Table 6.7: Wearer Penetration by Segment for Population 25-64 Years of Age, 2008 70
  478. Table 6.8: FDA-Approved Soft Contact Lenses, 2007-2009 72
  479. Table 6.9: FDA-Approved Rigid Gas Permeable Contact Lenses, 2007-2009 72
  480. Table 8.1: Self-Monitoring Blood Glucose Market Size in Asia Pacific, 2007 76
  481. Table 10.1: Portugal's Foreign Trade in Rubber Gloves, 2005-2007 86
  482. Table 10.2: Composition of Portugal's Imports of Rubber Gloves, 2005-2007 86
  483. Table 10.3: Portugal's Major Import Sources of Surgical Rubber Gloves, 2005-2007 87
  484. Table 10.4: Export of Medical Gloves from Malaysia by Glove Type, 2007 89
  485. Table 10.5: Malaysia's Export of Selected Rubber Products, 2005-2007 90
  486. Table 10.6: FDA-Approved Medical Gloves, 2008-2009 93
  487. Table 10.7: Gloves from Cardinal Health 99
  488. Table 10.8: Medical Gloves from Ansell Healthcare 100
  489. Table 10.9: Gloves from Mölnlycke HealthCare 101
  490. Table 10.10: Medical Gloves from Medline Industries 101
  491. Table 10.11: Medical Gloves from Sempermed 102
  492. Table 10.12: Medical Gloves from Kimberly-Clark 103
  493. Table 12.1: Silver Content of Selected Dressings 111
  494. Table 13.1: U.S. Disposable Surgical Gown Sales, 2003-2012 112
  495. Table 13.2: Worldwide Disposable Surgical Gown Sales, 2003-2012 113
  496. Table 13.3: FDA-Approved Surgical Gowns, 2006-2008 113
  497. Table 13.4: Surgical Gowns from Kimberly-Clark 114
  498. Table 13.5: Medical Gowns from Medline Industries 116
  499. Table 13.6: Medical Gowns from Mölnlycke HealthCare 117
  500. Table 13.7: Medical Gowns from 3M 117
  501. Table 13.8: U.S. Disposable Surgical Drape Sales, 2003-2012 118
  502. Table 13.9: Worldwide Disposable Surgical Drape Sales, 2003-2012 118
  503. Table 13.10: U.S. Isolation Gown Sales, 2003-2012 119
  504. Table 13.11: Worldwide Disposable Isolation Gown Sales, 2003-2012 120
  505. Table 13.12: Various Custom Kits and Trays Available in the Market 122
  506. Table 13.13: Disposable Custom Kits and Trays from DeRoyal Industries 123
  507. Table 13.14: Standard Surgical Trays from Medline 124
  508. Table 13.15: U.S. Shoe Cover Unit and Dollar Sales, 2003-2012 125
  509. Table 13.16: Worldwide Shoe Cover Unit and Dollar Sales, 2003-2012 126
  510. Table 13.17: Worldwide Market for Disposable Surgical Masks Unit Sales, 2003-2012 127
  511. Table 13.18: Worldwide Market for Disposable Surgical Masks Dollar Volume, 2003-2012 127
  512. Table 13.19: FDA-Approved Face Masks, 2004-2009 127
  513. Table 13.20: Medical Face Masks from 3M 128
  514. Table 13.21: Masks Offered by Kimberly-Clark Tecnol 129
  515. Table 13.22: Cardinal Health's Face Masks 130
  516. Table 13.23: U.S. Disposable Coverall Unit and Dollar Sales, 2003-2012 131
  517. Table 13.24: Worldwide Disposable Coverall Unit and Dollar Sales, 2003-2012 132
  518. Table 13.25: U.S. Lab Coat Unit and Dollar Sales, 2003-2012 133
  519. Table 13.26: Worldwide Lab Coat Unit and Dollar Sales, 2003-2012 133
  520. Table 13.27: Worldwide Market for Disposable Surgical Headwear Unit Sales, 2003-2012 134
  521. Table 13.28: Worldwide Market for Disposable Surgical Headwear Dollar Volume, 2003-2012 135
  522. Table 13.29: U.S. Disposable Goggle Unit and Dollar Sales, 2003-2012 135
  523. Table 13.30: Worldwide Disposable Goggle Unit and Dollar Sales, 2003-2012 136
  524. Table 13.31: U.S. Wipes Unit and Dollar Sales, 2003-2012 136
  525. Table 13.32: Worldwide Wipes Unit and Dollar Sales, 2003-2012 137
  526. Table 14.1: Terumo's Winged Needle Sets 148
  527. Table 14.2: Abbott's Net Sales by Segment, 2006-2008 150
  528. Table 14.3: Medtronic's Net Sales by Product Line and Operating Segment, 2006-2008 154
  529. Table 14.4: St Jude's Revenue from Cardiac Rhythm Segment, 2006-2008 161
  530. Table 14.5: St. Jude's Revenue from Cardiovascular Segment, 2006-2008 161
  531. Table 14.6: Johnson & Johnson's Major Consumer Franchise Sales, 2006-2008 170
  532. Table 14.7: Johnson & Johnson's Major Medical Devices and Diagnostics Franchise Sales, 2006-2008 171
  533. Table 14.8: Johnson & Johnson's Major Pharmaceutical Product Revenues, 2006-2008 172
  534. Table 14.9: Johnson & Johnson's R&D Expenditure by Segment, 2006-2008 172
  535. Table 14.10: Segment Reporting for Sempermed, 2007 and 2008 174
  536. Table 14.11: Semperit AG Holding, its Divisions and Production Companies, 2008 176
  537. Table 14.12: Sempermed's Gloves in Healthcare Sector, 2008 176
  538. Table 14.13: B. Braun's Global Locations, 2008 184
  539. Table 14.14: B. Braun at a Glance, 2006-2008 188
  540. Table 14.15: B. Braun Income Structure, 2005-2008 189
  541. Table 14.16: Mops and Wipes from Contec 203
  542. Table 14.17: Ansell's Sales by Business Segment, 2007 and 2008 204
  543. Table 14.18: Ansell's Sales by Geography, 2007 and 2008 205
  544. Table 14.19: Gloves from Ansell Ltd. 205
  545. Table 14.20: Ecolab's Sales by Segment, 2006-2008 209
  546. Table 14.21: Sales and Service Associates, Ecolab, 2005-2008 210
  547. Table 14.22: Covidien's Net Sales of Medical Devices by Groups of Products and Geography, 2006-2008 216
  548. Table 14.23: Covidien's Net Sales for Imaging Solutions by Group and Geography, 2006-2008 217
  549. Table 14.24: Covidien's Net Sales for Pharmaceutical Products by Group and Geography, 2006-2008 217
  550. Table 14.25: Covidien's Net Sales for Medical Supplies by Group, 2006-2008 218
  551. Table 14.26: Covidien's Net Sales by Geographic Area, 2006-2008 218
  552. Table 14.27: Covidien's Brands and Products, 2008 220
  553. Table 14.28: Disposable ECG Cable and Lead Systems from Covidien's Kendall Division 220
  554. Table 14.29: Monoject Magellan Safety Needles from Covidien 221
  555. Table 14.30: Kimberly-Clark's Selected Financial Data, 2003-2008 222
  556. Table 14.31: Kimberly-Clark's Consolidated Net Sales by Business Segments, 2006-2008 224
  557. Table 14.32: Kimberly-Clark's Consolidated Net Sales by Geographic Area, 2006-2008 225
  558. Table 14.33: Gloves from Kimberly-Clark 225
  559. Table 14.34: Enteral Feeding Tubes from Kimberly-Clark 226
  560. Table 14.35: Surgical Masks from Medline 226
  561. Table 14.36: Surgical Gloves from Medline 227
  562. Table 14.37: 3M HealthCare Business Excluding Pharmaceuticals, 2005-2008 228
  563. Table 14.38: Protective Apparel Products from Alpha Pro Tech 233
  564. Table 14.39: Medical Disposable Products from Graham Medical 235
  565. Table 14.40: FDA-Approved Products from Dynarex Corp. 237
  566. Table 14.41: Financial Figures of Hartmann Group, 2003-2008 239
  567. Table 14.42: Hartmann Group's Wound Management Segment Revenue, 2006-2008 239
  568. Table 14.43: Hartmann's Incontinence Management Business Segment, 2006-2008 240
  569. Table 14.44: Surgical Drapes, Gowns and Glove Sets from Hartmann 240
  570. Table 14.45: Ahlstrom's Business Overview, 2008 248
  571. Table 14.46: Ahlstrom's Market Position, 2008 249
  572. Table 14.47: Key Figures of Ahlstrom's Fiber Composites, 2005-2007 250
  573. Table 14.48: Ahlstrom's Growth in Investments and Acquisitions, 2007 251
  574. Table 14.49: Ansell's Occupational Healthcare Segment Performance, 2007 and 2008 253
  575. Table 14.50: Ansell's Sales by Segment, 2007 and 2008 253
  576. Table 14.51: Ansell's Sales by Region, 2007 and 2008 254
  577. Table 14.52: Ansell's Business and Regional Segments, 2007 and 2008 254
  578. Table 14.53: Baxter's Net Sales by Segment, 2005-2008 256
  579. Table 14.54: Baxter's Net Sales in the Bioscience Segment, 2005-2008 256
  580. Table 14.55: Baxter's Medication Delivery Segment Net Sales, 2005-2008 257
  581. Table 14.56: Baxter's Net Sales in Renal Segment, 2005-2008 258
  582. Table 14.57: Baxter's R&D Expenditure, 2006-2008 258
  583. Table 14.58: BD's Medical Segment Revenues by Organizational Unit, 2007 and 2008 259
  584. Table 14.59: BD's Diagnostic Segment Revenues by Organizational Unit, 2007 and 2008 260
  585. Table 14.60: BD's Bioscience Segment Revenues by Organizational Units, 2007 and 2008 261
  586. Table 14.61: BD's Product List 262
  587. Table 14.62: Boston's Cardiac Rhythm Management (CRM) Product Sales, 2007 and 2008 264
  588. Table 14.63: Boston's CRM Sales by Product, 2007 and 2008 264
  589. Table 14.64: Boston's Endosurgery Sales by Product, 2007 and 2008 266
  590. Table 14.65: Boston's Worldwide Net Sales by Division, 2006-2008 268
  591. Table 14.66: Coloplast's Performance by Geographical Market, 2006/2007 and 2007/2008 270
  592. Table 14.67 Top Glove Corporation's Profile, 2009 272

Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.